SIGA Technologies, Inc. (SIGA)
USD 5.63
(3.68%)
USD 5.63
(3.68%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 83.62 Million USD | 95.83% |
| 2022 | 42.7 Million USD | -52.07% |
| 2021 | 89.09 Million USD | 5.43% |
| 2020 | 84.5 Million USD | 16797.12% |
| 2019 | 500.08 Thousand USD | -99.86% |
| 2018 | 355.09 Million USD | 1983.9% |
| 2017 | -18.84 Million USD | 39.23% |
| 2016 | -31.01 Million USD | -0.2% |
| 2015 | -30.95 Million USD | 85.24% |
| 2014 | -209.66 Million USD | -791.59% |
| 2013 | -23.51 Million USD | -4.35% |
| 2012 | -22.53 Million USD | 28.19% |
| 2011 | -31.38 Million USD | -146.66% |
| 2010 | -12.72 Million USD | -7.1% |
| 2009 | -11.87 Million USD | -35.96% |
| 2008 | -8.73 Million USD | -17.07% |
| 2007 | -7.46 Million USD | -9.58% |
| 2006 | -6.81 Million USD | -168.94% |
| 2005 | -2.53 Million USD | 73.2% |
| 2004 | -9.44 Million USD | -78.44% |
| 2003 | -5.29 Million USD | -57.35% |
| 2002 | -3.36 Million USD | -3.17% |
| 2001 | -3.26 Million USD | 53.95% |
| 2000 | -7.08 Million USD | -102.39% |
| 1999 | -3.5 Million USD | 32.69% |
| 1998 | -5.2 Million USD | -126.09% |
| 1997 | -2.3 Million USD | -64.29% |
| 1996 | -1.4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 11.27 Million USD | -87.7% |
| 2024 Q2 | 1.07 Million USD | -90.42% |
| 2023 Q2 | -4.63 Million USD | -120.0% |
| 2023 Q3 | -1.3 Million USD | 71.77% |
| 2023 Q4 | 91.67 Million USD | 7102.29% |
| 2023 Q1 | -2.1 Million USD | -16.82% |
| 2023 FY | 83.62 Million USD | 95.83% |
| 2022 Q4 | -1.8 Million USD | -104.21% |
| 2022 FY | 42.7 Million USD | -52.07% |
| 2022 Q1 | -1.43 Million USD | -101.53% |
| 2022 Q2 | 3.07 Million USD | 313.41% |
| 2022 Q3 | 42.87 Million USD | 1296.19% |
| 2021 Q3 | -2.94 Million USD | -267240.56% |
| 2021 Q1 | -1.98 Million USD | -107.42% |
| 2021 Q2 | 1102.00 USD | 100.06% |
| 2021 Q4 | 94.02 Million USD | 3293.9% |
| 2021 FY | 89.09 Million USD | 5.43% |
| 2020 Q1 | -3.99 Million USD | -15.24% |
| 2020 FY | 84.5 Million USD | 16797.12% |
| 2020 Q3 | 32.89 Million USD | 14.24% |
| 2020 Q2 | 28.79 Million USD | 820.28% |
| 2020 Q4 | 26.8 Million USD | -18.53% |
| 2019 Q4 | -3.46 Million USD | -625.21% |
| 2019 Q2 | -1.7 Million USD | -177.8% |
| 2019 Q1 | 2.19 Million USD | 139.56% |
| 2019 FY | 500.08 Thousand USD | -99.86% |
| 2019 Q3 | 660.57 Thousand USD | 138.74% |
| 2018 Q2 | -3.7 Million USD | 18.2% |
| 2018 FY | 355.09 Million USD | 1983.9% |
| 2018 Q1 | -4.53 Million USD | 6.89% |
| 2018 Q3 | 368.88 Million USD | 10043.82% |
| 2018 Q4 | -5.54 Million USD | -101.5% |
| 2017 FY | -18.84 Million USD | 39.23% |
| 2017 Q4 | -4.87 Million USD | 13.81% |
| 2017 Q3 | -5.65 Million USD | -39.23% |
| 2017 Q2 | -4.05 Million USD | 4.93% |
| 2017 Q1 | -4.26 Million USD | 35.4% |
| 2016 Q1 | -7.05 Million USD | 60.68% |
| 2016 FY | -31.01 Million USD | -0.2% |
| 2016 Q3 | -8.06 Million USD | 13.17% |
| 2016 Q2 | -9.28 Million USD | -31.53% |
| 2016 Q4 | -6.6 Million USD | 18.03% |
| 2015 FY | -30.95 Million USD | 85.24% |
| 2015 Q3 | -3.62 Million USD | 16.25% |
| 2015 Q1 | -5.03 Million USD | 71.29% |
| 2015 Q2 | -4.33 Million USD | 14.03% |
| 2015 Q4 | -17.95 Million USD | -394.78% |
| 2014 Q2 | -4.74 Million USD | 15.82% |
| 2014 Q1 | -5.63 Million USD | 13.43% |
| 2014 Q3 | -181.72 Million USD | -3728.67% |
| 2014 Q4 | -17.55 Million USD | 90.34% |
| 2014 FY | -209.66 Million USD | -791.59% |
| 2013 Q1 | -5.8 Million USD | -10.42% |
| 2013 FY | -23.51 Million USD | -4.35% |
| 2013 Q2 | -5.63 Million USD | 2.99% |
| 2013 Q3 | -5.56 Million USD | 1.23% |
| 2013 Q4 | -6.51 Million USD | -17.07% |
| 2012 Q3 | -5.39 Million USD | 14.79% |
| 2012 Q1 | -5.54 Million USD | 28.58% |
| 2012 FY | -22.53 Million USD | 28.19% |
| 2012 Q4 | -5.25 Million USD | 2.54% |
| 2012 Q2 | -6.33 Million USD | -14.12% |
| 2011 Q4 | -7.76 Million USD | -28.56% |
| 2011 FY | -31.38 Million USD | -146.66% |
| 2011 Q3 | -6.04 Million USD | 45.6% |
| 2011 Q2 | -11.1 Million USD | -71.91% |
| 2011 Q1 | -6.46 Million USD | -52.14% |
| 2010 Q2 | -3.02 Million USD | 0.6% |
| 2010 Q1 | -3.04 Million USD | 18.45% |
| 2010 FY | -12.72 Million USD | -7.1% |
| 2010 Q4 | -4.24 Million USD | -76.11% |
| 2010 Q3 | -2.41 Million USD | 20.21% |
| 2009 Q2 | -2.5 Million USD | 14.67% |
| 2009 FY | -11.87 Million USD | -35.96% |
| 2009 Q4 | -3.72 Million USD | -42.36% |
| 2009 Q3 | -2.61 Million USD | -4.4% |
| 2009 Q1 | -2.94 Million USD | -15.43% |
| 2008 FY | -8.73 Million USD | -17.07% |
| 2008 Q4 | -2.54 Million USD | -19.35% |
| 2008 Q3 | -2.13 Million USD | -3.25% |
| 2008 Q2 | -2.06 Million USD | -3.99% |
| 2008 Q1 | -1.98 Million USD | 4.01% |
| 2007 Q3 | -1.58 Million USD | 21.16% |
| 2007 Q2 | -2.01 Million USD | -11.87% |
| 2007 Q1 | -1.79 Million USD | 8.22% |
| 2007 FY | -7.46 Million USD | -9.58% |
| 2007 Q4 | -2.07 Million USD | -30.68% |
| 2006 Q4 | -1.95 Million USD | -104.06% |
| 2006 Q2 | -2.57 Million USD | -96.2% |
| 2006 Q1 | -1.31 Million USD | -152.53% |
| 2006 FY | -6.81 Million USD | -168.94% |
| 2006 Q3 | -959.5 Thousand USD | 62.79% |
| 2005 Q2 | -1.62 Million USD | -45.65% |
| 2005 Q3 | 721.77 Thousand USD | 144.53% |
| 2005 Q4 | -520.44 Thousand USD | -172.11% |
| 2005 FY | -2.53 Million USD | 73.2% |
| 2005 Q1 | -1.11 Million USD | 64.36% |
| 2004 Q3 | -1.86 Million USD | 25.52% |
| 2004 Q4 | -3.12 Million USD | -67.42% |
| 2004 FY | -9.44 Million USD | -78.44% |
| 2004 Q1 | -1.95 Million USD | -20.84% |
| 2004 Q2 | -2.5 Million USD | -28.04% |
| 2003 Q3 | -1.57 Million USD | -29.65% |
| 2003 Q1 | -888.59 Thousand USD | 14.99% |
| 2003 Q4 | -1.61 Million USD | -2.85% |
| 2003 FY | -5.29 Million USD | -57.35% |
| 2003 Q2 | -1.21 Million USD | -36.6% |
| 2002 Q1 | -724.81 Thousand USD | 28.9% |
| 2002 FY | -3.36 Million USD | -3.17% |
| 2002 Q4 | -1.04 Million USD | -64.8% |
| 2002 Q3 | -634.31 Thousand USD | 33.97% |
| 2002 Q2 | -960.64 Thousand USD | -32.54% |
| 2001 Q1 | -191.46 Thousand USD | 89.55% |
| 2001 FY | -3.26 Million USD | 53.95% |
| 2001 Q4 | -1.01 Million USD | 35.82% |
| 2001 Q3 | -1.58 Million USD | -256.92% |
| 2001 Q2 | -444.99 Thousand USD | -132.42% |
| 2000 Q2 | -1.26 Million USD | 15.13% |
| 2000 Q1 | -1.49 Million USD | -113.34% |
| 2000 FY | -7.08 Million USD | -102.39% |
| 2000 Q3 | -2.49 Million USD | -96.52% |
| 2000 Q4 | -1.83 Million USD | 26.45% |
| 1999 Q4 | -700 Thousand USD | 22.22% |
| 1999 Q1 | -1 Million USD | -11.11% |
| 1999 FY | -3.5 Million USD | 32.69% |
| 1999 Q3 | -900 Thousand USD | 0.0% |
| 1999 Q2 | -900 Thousand USD | 10.0% |
| 1998 Q4 | -900 Thousand USD | 35.71% |
| 1998 Q1 | -900 Thousand USD | 0.0% |
| 1998 Q2 | -2 Million USD | -122.22% |
| 1998 Q3 | -1.4 Million USD | 30.0% |
| 1998 FY | -5.2 Million USD | -126.09% |
| 1997 FY | -2.3 Million USD | -64.29% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1997 Q3 | -200 Thousand USD | -300.0% |
| 1997 Q4 | -900 Thousand USD | -350.0% |
| 1996 FY | -1.4 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 153.754% |
| Theratechnologies Inc. | -10.62 Million USD | 886.875% |
| Safety Shot Inc | -12.18 Million USD | 786.311% |
| Cosmos Health Inc. | -21.83 Million USD | 483.035% |
| Cronos Group Inc. | -81.37 Million USD | 202.76% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 59.997% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 313.575% |
| Organogenesis Holdings Inc. | 12.52 Million USD | -567.634% |
| Universe Pharmaceuticals INC | -3.52 Million USD | 2471.038% |
| ProPhase Labs, Inc. | -21.61 Million USD | 486.902% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | 1878.795% |
| Dynavax Technologies Corporation | -37.02 Million USD | 325.832% |
| Radius Health, Inc. | -3.92 Million USD | 2230.476% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | 3424.61% |
| Alvotech | -354.86 Million USD | 123.565% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 1847.46% |
| Alpha Teknova, Inc. | -35.56 Million USD | 335.135% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 152.466% |
| SCYNEXIS, Inc. | 72.66 Million USD | -15.071% |
| Harrow Health, Inc. | 580 Thousand USD | -14317.442% |
| Biofrontera Inc. | -22.67 Million USD | 468.749% |
| DURECT Corporation | -36.88 Million USD | 326.714% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | 1687.041% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | -78.027% |
| OptiNose, Inc. | -22.74 Million USD | 467.598% |
| RedHill Biopharma Ltd. | 12.63 Million USD | -561.979% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 653.709% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | 1446.379% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | -796.165% |
| Shineco, Inc. | -17.06 Million USD | 589.991% |
| Phibro Animal Health Corporation | 53.31 Million USD | -56.844% |
| Procaps Group S.A. | 52.32 Million USD | -59.814% |
| TherapeuticsMD, Inc. | -8.52 Million USD | 1081.124% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | 1865.379% |
| Viatris Inc. | 766.2 Million USD | 89.086% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 1847.46% |
| Rockwell Medical, Inc. | -6.67 Million USD | 1353.691% |
| Incannex Healthcare Limited | -30.04 Million USD | 378.357% |
| Aytu BioPharma, Inc. | -5.25 Million USD | 1691.571% |
| Tilray Brands, Inc. | -174.74 Million USD | 147.853% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 49.916% |
| PetIQ, Inc. | 60.01 Million USD | -39.334% |
| Silver Spike Investment Corp. | 7.34 Million USD | -1039.236% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 66.672% |
| Journey Medical Corporation | -2.07 Million USD | 4133.824% |
| Alimera Sciences, Inc. | -1.47 Million USD | 5784.648% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 714.077% |
| Assertio Holdings, Inc. | -243.53 Million USD | 134.336% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | 1519.141% |
| Embecta Corp. | 221.5 Million USD | 62.248% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 517.062% |
| Procaps Group, S.A. | 38.97 Million USD | -114.562% |
| PainReform Ltd. | -9.58 Million USD | 972.508% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 160.661% |
| Hempacco Co., Inc. | -8.81 Million USD | 1048.916% |
| Talphera, Inc. | -16.88 Million USD | 595.122% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 4.624% |
| Alvotech | -354.86 Million USD | 123.565% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 77.068% |
| Kamada Ltd. | 10.06 Million USD | -730.894% |
| Indivior PLC | -4 Million USD | 2190.529% |
| Currenc Group, Inc. | -6.64 Million USD | 1358.259% |
| Evoke Pharma, Inc. | -7.43 Million USD | 1225.318% |
| Flora Growth Corp. | -50.35 Million USD | 266.067% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 517.062% |
| Evolus, Inc. | -49.23 Million USD | 269.848% |
| HUTCHMED (China) Limited | 18.37 Million USD | -355.081% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 57.55% |
| Akanda Corp. | -10.05 Million USD | 931.938% |